Icahn School of Medicine, The Mount Sinai Hospital, New York, NY.
American College of Surgeons, National Cancer Database, Chicago, IL.
Med Care. 2019 Sep;57(9):728-733. doi: 10.1097/MLR.0000000000001143.
Regionalization to higher volume centers has been proposed as a mechanism to improve short-term outcomes following complex surgery.
The objective of this study was to assess trends in regionalization and mortality for patients undergoing radical cystectomy (RC).
An observational study of patients receiving RC in the United States from 2004 to 2013.
Data for patients receiving RC were extracted from the National Cancer Database.
The primary exposure was hospital volume; low-volume hospitals (LVH) included those with <5 RC/year and high-volume hospitals (HVH) were those with ≥30 RC/year. Trends in the volume were assessed, as were 30- and 90-day mortality. Cochrane-Armitage tests were performed for volume, and propensity score-weighted proportional hazard regression was used to assess mortality.
A total of 47,028 RC were performed in 1162 hospitals from 2004 to 2013. The proportion of RC at LVH declined from 29% to 17% (P<0.01), whereas that of HVH increased from 16% to 33% (P<0.01). Unadjusted 30- (P=0.02) and 90-day (P<0.001) mortality decreased, and the absolute decrease was greatest at LVH (4.8% vs. 2.6%, P=0.03), whereas rates for HVH remained stable (1.9% vs. 1.4%, P=0.34). Following risk-adjustment, relative to treatment at HVH, treatment at LVH was associated with increased 30-day (hazard ratio: 1.66, 95% CI: 1.53-1.80) and 90-day mortality (hazard ratio: 1.37, 95% confidence interval: 1.30-1.44).
Regionalization of RC to HVH was observed from 2004 to 2013. Treatment at LVH was associated with 66% and 33% relative increases in hazard of death at 30 and 90 days, respectively. These findings support the selective referral of complex cases to higher volume centers.
将手术集中到高容量中心被提议作为一种改善复杂手术后短期结果的机制。
本研究的目的是评估接受根治性膀胱切除术(RC)的患者的区域化和死亡率趋势。
这是一项在美国进行的观察性研究,研究对象为 2004 年至 2013 年期间接受 RC 的患者。
从国家癌症数据库中提取接受 RC 的患者数据。
医院容量;低容量医院(LVH)包括每年接受 RC 手术少于 5 例的医院,高容量医院(HVH)包括每年接受 RC 手术 30 例以上的医院。评估了容量的趋势,以及 30 天和 90 天的死亡率。对容量进行了 Cochrane-Armitage 检验,并用倾向评分加权比例风险回归来评估死亡率。
2004 年至 2013 年,共在 1162 家医院进行了 47028 例 RC。LVH 行 RC 的比例从 29%降至 17%(P<0.01),而 HVH 行 RC 的比例从 16%增至 33%(P<0.01)。未调整的 30 天(P=0.02)和 90 天(P<0.001)死亡率下降,LVH 的绝对降幅最大(4.8%比 2.6%,P=0.03),而 HVH 的死亡率保持稳定(1.9%比 1.4%,P=0.34)。在风险调整后,与 HVH 治疗相比,LVH 治疗与 30 天(风险比:1.66,95%置信区间:1.53-1.80)和 90 天(风险比:1.37,95%置信区间:1.30-1.44)的死亡风险增加相关。
2004 年至 2013 年,RC 向 HVH 的区域化趋势明显。在 LVH 治疗的患者中,30 天和 90 天的死亡风险分别相对增加了 66%和 33%。这些发现支持将复杂病例选择性转诊到高容量中心。